心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2018 ASE指南：超声增强剂在超声心动图检查中的临床应用（更新版）

2018-03-03 美国超声心动图学会 J Am Soc Echocardiogr. 2018 Mar;31(3):241-274.

超声增强剂超声心动图

2018年3月，美国超声心动图学会(ASE)发布了超声增强剂在超声心动图检查中的临床应用指南，超声增强剂的应用是超声心动图检查的重要组成部分，本文主要建议是依据2015年ACC/AHA临床实践指南，主要内容涉及对比超声增强剂，临床应用，安全性，新兴应用，成本效益等。

中文标题：

2018 ASE指南：超声增强剂在超声心动图检查中的临床应用（更新版）

英文标题：

Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update.

发布机构：

美国超声心动图学会

发布日期：

2018-03-03

简要介绍：

2018年3月，美国超声心动图学会(ASE)发布了超声增强剂在超声心动图检查中的临床应用指南，超声增强剂的应用是超声心动图检查的重要组成部分，本文主要建议是依据2015年ACC/AHA临床实践指南，主要内容涉及对比超声增强剂，临床应用，安全性，新兴应用，成本效益等。

 

拓展指南：与超声相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 ASE指南：超声增强剂在超声心动图检查中的临床应用（更新版）)] GetToolGuiderByIdResponse(projectId=1, id=142951c001566192, title=2018 ASE指南：超声增强剂在超声心动图检查中的临床应用（更新版）, enTitle=Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update., guiderFrom=J Am Soc Echocardiogr. 2018 Mar;31(3):241-274., authorId=null, author=, summary=2018年3月，美国超声心动图学会(ASE)发布了超声增强剂在超声心动图检查中的临床应用指南，超声增强剂的应用是超声心动图检查的重要组成部分，本文主要建议是依据2015年ACC/AHA临床实践指南，主要内容涉及对比超声增强剂，临床应用，安全性，新兴应用，成本效益等。 , cover=, journalId=null, articlesId=null, associationId=111, associationName=美国超声心动图学会, associationIntro=美国超声心动图学会（ASE ,American Society of Echocardiography）成立于1975年,是世界上最大的心脏影像国际组织。提供心血管系统超声图像、心脏超声心动图指南。, copyright=0, guiderPublishedTime=Sat Mar 03 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年3月，美国超声心动图学会(ASE)发布了超声增强剂在超声心动图检查中的临床应用指南，超声增强剂的应用是超声心动图检查的重要组成部分，本文主要建议是依据2015年ACC/AHA临床实践指南，主要内容涉及对比超声增强剂，临床应用，安全性，新兴应用，成本效益等。 </P> <P> </P>拓展指南：<strong>与<font color=red>超声</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=ee4361c0015530d0" title="经食管超声心动图临床应用中国专家共识" target=_blank>经食管超声心动图临床应用中国专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9af121c00155021e" title="2018 SHM立场声明：超声引导下成人胸腔穿刺术" target=_blank>2018 SHM立场声明：超声引导下成人胸腔穿刺术</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=156051c001536928" title="超声刀在胸部淋巴结清扫中的应用—《胸腔镜手术超声刀规范使用专家共识（2017年版）》解读" target=_blank>超声刀在胸部淋巴结清扫中的应用—《胸腔镜手术超声刀规范使用专家共识（2017年版）》解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=4f1961c001536582" title="2017 实践指南：内镜超声引导下腹腔神经丛阻滞" target=_blank>2017 实践指南：内镜超声引导下腹腔神经丛阻滞</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=98e461c001531259" title="超声引导下真空辅助乳腺活检手术专家共识及操作指南（2017版）" target=_blank>超声引导下真空辅助乳腺活检手术专家共识及操作指南（2017版）</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E8%B6%85%E5%A3%B0" target=_blank>有关超声更多指南</a></ul>, tagList=[TagDto(tagId=71434, tagName=超声增强剂), TagDto(tagId=1796, tagName=超声心动图)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7903, appHits=329, showAppHits=0, pcHits=5668, showPcHits=3071, likes=129, shares=16, comments=5, approvalStatus=1, publishedTime=Sat Mar 10 21:57:06 CST 2018, publishedTimeString=2018-03-03, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Mar 10 21:57:06 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 14:36:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ASE指南：超声增强剂在超声心动图检查中的临床应用（更新版）)])
2018 ASE指南：超声增强剂在超声心动图检查中的临床应用（更新版）
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1057481, encodeId=8e21105e481b7, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 13:59:22 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296085, encodeId=eb922960854b, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Mar 14 07:36:43 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295800, encodeId=8e22295800d9, content=学习了.多谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:55:28 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295001, encodeId=113329500147, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Mar 11 00:12:38 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294964, encodeId=9a3029496463, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Mar 10 22:50:45 CST 2018, time=2018-03-10, status=1, ipAttribution=)]
    2021-10-04 H8888888

    不错 谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1057481, encodeId=8e21105e481b7, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 13:59:22 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296085, encodeId=eb922960854b, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Mar 14 07:36:43 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295800, encodeId=8e22295800d9, content=学习了.多谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:55:28 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295001, encodeId=113329500147, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Mar 11 00:12:38 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294964, encodeId=9a3029496463, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Mar 10 22:50:45 CST 2018, time=2018-03-10, status=1, ipAttribution=)]
    2018-03-14 大爰

    学习了谢谢分享!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1057481, encodeId=8e21105e481b7, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 13:59:22 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296085, encodeId=eb922960854b, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Mar 14 07:36:43 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295800, encodeId=8e22295800d9, content=学习了.多谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:55:28 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295001, encodeId=113329500147, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Mar 11 00:12:38 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294964, encodeId=9a3029496463, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Mar 10 22:50:45 CST 2018, time=2018-03-10, status=1, ipAttribution=)]
    2018-03-13 ms2296823935859672

    学习了.多谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1057481, encodeId=8e21105e481b7, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 13:59:22 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296085, encodeId=eb922960854b, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Mar 14 07:36:43 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295800, encodeId=8e22295800d9, content=学习了.多谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:55:28 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295001, encodeId=113329500147, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Mar 11 00:12:38 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294964, encodeId=9a3029496463, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Mar 10 22:50:45 CST 2018, time=2018-03-10, status=1, ipAttribution=)]
    2018-03-11 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1057481, encodeId=8e21105e481b7, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 13:59:22 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296085, encodeId=eb922960854b, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Mar 14 07:36:43 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295800, encodeId=8e22295800d9, content=学习了.多谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Tue Mar 13 10:55:28 CST 2018, time=2018-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=295001, encodeId=113329500147, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Mar 11 00:12:38 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294964, encodeId=9a3029496463, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Mar 10 22:50:45 CST 2018, time=2018-03-10, status=1, ipAttribution=)]
    2018-03-10 惠映实验室

    学习.谢谢分享.

    0